Trial Profile
Clinical Trials Insight: 700023978
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2007
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- Sponsors Alkermes
- 20 Jun 2007 New trial record.